|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.17 USD | 0.00% |
|
+1.88% | -68.64% |
| Apr. 29 | Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment | MT |
| Apr. 18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
On August 22, 2023, Immix Biopharma, Inc. closed the transaction.
| 1st Jan change | Capi. | |
|---|---|---|
| -68.64% | 57.28M | |
| -4.24% | 86.85B | |
| +2.76% | 40.16B | |
| -16.48% | 31.28B | |
| +57.86% | 25.27B | |
| -13.58% | 15.33B | |
| -9.12% | 11.96B | |
| -42.56% | 11.61B | |
| +6.89% | 8.83B | |
| -10.53% | 7.94B |
IMMIX BIOPHARMA, INC. 
